Tag: cancer cachexia market outlook

  • 2024 Cancer Cachexia Market Overview: Key Insights on Size, Share, and Trends

    2024 Cancer Cachexia Market Overview: Key Insights on Size, Share, and Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Cancer Cachexia Market from 2024 to 2033?
    The cancer cachexia market is expected to grow from $2.33 billion in 2023 to $2.47 billion in 2024, reflecting a CAGR of 5.9%. Growth factors include improved understanding of cancer biology and increased treatment options.

    The cancer cachexia market is expected to grow to $3.14 billion by 2028 at a CAGR of 6.2%. Contributing factors include rising awareness of cachexia management, an aging population, novel therapeutic approaches, increased healthcare spending, and supportive government initiatives. Trends will focus on R&D, expanding treatment options, and advancements in supportive care.

    Claim Your Free Sample of the Global Cancer Cachexia Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15527&type=smp

    What Key Factors Are Fueling the Growth of the Cancer Cachexia Market?
    The increasing prevalence of cancer is projected to advance the cancer cachexia market. Cancer involves uncontrolled cell growth that disrupts bodily functions, with cases rising due to lifestyle changes and improved detection. Increased awareness and advancements in technology facilitate earlier diagnoses of cancer cachexia. For instance, the Australian Bureau of Statistics reported approximately 1.8% of the population had cancer in 2022. Consequently, the rising incidence of cancer is driving the cancer cachexia market.

    What Are the Major Segments of the Cancer Cachexia Market?
    1) By Therapeutics: Progestogens; Corticosteroids; Combination Therapies; Other Therapeutics
    2) By Mechanism Of Action: Appetite Stimulators; Weight Loss Stabilizers; Other Mechanisms Of Actions
    3) By Distribution Channel: Hospital Stores; Retail Pharmacy Stores; Online Pharmacies

    What New Trends Are Transforming the Cancer Cachexia Market?
    Major firms in the cancer cachexia market are innovating medications like ghrelin receptor agonists to address the severe symptoms and complications of cachexia, aiming to enhance patient outcomes. In April 2021, Helsinn, a Swiss pharmaceutical company, launched Adlumiz (anamorelin) in Japan for treating cancer cachexia in various malignancies. Adlumiz is designed to stimulate appetite and increase muscle mass, receiving approval for its effectiveness in cancer patients.

    Order Now for Fast Delivery of Your Cancer Cachexia Market Report!
    https://www.thebusinessresearchcompany.com/report/cancer-cachexia-global-market-report

    Which Regions Are Driving Growth in the Cancer Cachexia Market?
    North America was the largest region in the cancer cachexia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer cachexia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Cancer Cachexia Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cancer cachexia market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Cancer Cachexia Market Include

    1. Cancer Cachexia Market Executive Summary
    2. Cancer Cachexia Market Segments
    3. Cancer Cachexia Market Size And Template Market Growth Rate
    4.  Key Cancer Cachexia Market Trends
    5. Major Cancer Cachexia Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Cancer Cachexia Market
    26. Top Cancer Cachexia Companies
    27. Cancer Cachexia Market Opportunities And Strategies
    28. Cancer Cachexia Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Breast Cancer Drugs Global Market Report 2024
    https://www.thebusinessresearchcompany.com/sample_request?id=2566&type=smp

    Breast Cancer Diagnostics Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

    Bone Cancer Treatment Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/bone-cancer-treatment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Cancer Cachexia Market 2024

    5 Key Insights On The Cancer Cachexia Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Cancer Cachexia Global Market Report 2024, the cancer cachexia market is expected to show significant growth in the forecast period.

    The cancer cachexia market has experienced robust growth in recent years and is expected to continue expanding. This growth is driven by various factors, including an aging population, an increased prevalence of cancer, and advancements in treatment options.

    Current Market Size and Growth

    • 2023 Market Size: $2.33 billion
    • 2024 Market Size: $2.47 billion
    • CAGR: 5.9% from 2023 to 2024

    This growth is attributed to an improved understanding of cancer biology, a greater focus on patient-centered care, and increased awareness among healthcare providers.

    Future Market Projections

    • 2028 Market Size: $3.14 billion
    • CAGR: 6.2% from 2024 to 2028

    Key factors contributing to this growth include rising awareness about cachexia management, expanding geriatric population, adoption of novel therapeutic approaches, increased healthcare expenditure, and supportive government initiatives.

    View More On The Cancer Cachexia Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cancer-cachexia-global-market-report

    Impact of Cancer Prevalence on the Market

    The rising prevalence of cancer significantly impacts the cancer cachexia market:

    • Increasing Cancer Cases: Lifestyle changes, environmental factors, and an aging population contribute to the growing number of cancer cases.
    • Improved Diagnosis: Enhanced diagnostic methods lead to earlier detection, resulting in a higher number of reported cancer cachexia cases.
    • Growing Awareness: More healthcare professionals recognize cachexia symptoms, enabling earlier intervention and treatment.

    For instance, in Australia, approximately 1.8% of the population, or 456,200 individuals, had cancer in 2022. Additionally, around 151,000 new cancer diagnoses were made in 2021.

    Key Players in the Market

    The cancer cachexia market features several major companies actively developing innovative treatments and expanding their offerings:

    • Leading Companies: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, and others.
    • Focus on Innovation: These companies are investing in research and development to introduce new therapies and improve existing ones, focusing on patient outcomes and quality of life.

    Innovative Treatments in the Cancer Cachexia Market

    Major companies are developing innovative treatments to manage cancer cachexia:

    • Ghrelin Receptor Agonists: Medications like ghrelin receptor agonists activate pathways to regulate body weight, muscle mass, and appetite.
    • Example: Helsinn’s Adlumiz (anamorelin), launched in Japan in 2021, is a ghrelin receptor agonist approved to treat cancer cachexia in various cancers, showing effectiveness in increasing body weight and muscle mass.

    Strategic Acquisitions to Enhance Cancer Therapies

    Acquisitions play a significant role in advancing cancer cachexia treatment options:

    • LG Chem’s Acquisition of AVEO Oncology: In January 2023, LG Chem acquired AVEO Oncology to diversify its product portfolio and enhance its capabilities in drug development. This acquisition aims to accelerate innovation in cancer therapies and offer potential treatments for cancer cachexia.

    Market Segmentation

    The cancer cachexia market is segmented based on therapeutics, mechanisms of action, and distribution channels:

    • By Therapeutics: Progestogens, Corticosteroids, Combination Therapies, Other Therapeutics
    • By Mechanism of Action: Appetite Stimulators, Weight Loss Stabilizers, Other Mechanisms of Actions
    • By Distribution Channel: Hospital Stores, Retail Pharmacy Stores, Online Pharmacies

    Regional Insights

    • Largest Region (2023): North America
    • Fastest-Growing Region: Asia-Pacific

    The cancer cachexia market is poised for significant growth in the coming years, driven by increasing cancer prevalence, innovative treatments, and strategic acquisitions. With advancements in diagnosis and supportive care, the market will likely continue expanding, offering improved options for managing cancer cachexia.

    Request A Sample Of The Global Cancer Cachexia Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15527&type=smp